Non-Animal Softgel Capsules Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Non-Animal Softgel Capsules Market By Material Type (Starch, Carrageenan-Starch Blends, and Others), By Application (Pharmaceuticals, Healthcare Supplements, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global non-animal softgel capsules market size USD 360.2 million in 2020 and expected to reach USD 525.8 million by 2027, at a CAGR of 5.5% during forecast period 2021-2027. Gelatin is used as major raw material while making Softgel capsules. There is an increasing demand for natural and green products from health conscious customers hence driving the market growth and bringing more opportunities in for the players. Moreover, rise in awareness about the health among the population, increase in the demand for non-animal softgel capsules due to surge in vegan population and religious myths, wide range of advantages with softgel capsules such as compatibility with high temperature, and launch of newer products are anticipated to propel the non-animal softgel capsules market over the forecast years. However, Fluctuations in raw material prices, adoption of alternate nutritional products such as powders and injections, and complications in the manufacturing process are anticipated to restrain the growth of market in the near future. Adoption of nutritional supplements due to wide benefits with the products is a key factor surge the growth of global non-animal softgel capsules market over the forecast years. Softgel capsules are easily absorb and may enhance the bioavailability of the products. Rapid growth in global population demanding for vegan products may generate the revenue of market. Currently, approximately 45% capsules are made up of pork meat and bones and only 3% of the global softgel capsules production is from halal or permissible ingredients which is a major concern for the Muslim population may leads to surge in the adoption of vegan softgel capsules over the forecast period.

Non-Animal Softgel Capsules Market

MARKET SUMMARY
-
5.5% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 5.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Non-Animal Softgel Capsules Market

  • The report on global non-animal softgel capsules market gives historical, current and future market sizes (US$ Mn) on the basis of material type, application, and region.
  • non-animal softgel capsules market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global non-animal softgel capsules products.
Key Players
  • Softigel (Procaps Laboratories)
  • Sirio Pharma Co., Ltd.
  • Robinson Pharma, Inc.
  • Patheon
  • EuroCaps
  • Catalent, Inc.
Non-Animal Softgel Capsules Market

Drivers And Restraints

The increasing interest amid the customers regarding health awareness lead to the demand for health supplements. People become more conscious about their health and body deficiencies and hence opting for the nutritional and vitamin supplements, which are easy to swallow and formed in oral dose. Hence, Softgel capsules are getting more significance among infants, children and old people as they get well-absorbed in body. People become more conscious about their health hence there is growing demand for nutrition products and consequently Softgel Capsule market increases. Sport supplement manufacturers will obtain huge market share during the forecast period as there will be growing demand for sport nutrition products among many consumers in oral dosage format.


North-America got significant share

Non-Animal Softgel Capsules Market

In 2019, North America accounted for highest revenue share followed by Europe and Asia Pacific. North America dominated the market with 45.4% in global non-animal softgel capsules market and the region anticipated to raise over the forecast years with noteworthy growth rate due to rise in demand for nutritional supplements such as omega-3-fatty acids in USA and Canada. Moreover, market players emphasis on R&D activities for the development of advanced products also upwelling the market in the near future. Europe held significant market share and projected to grow at 7.3% CAGR over 2020-2026 owing to increase in vegan population in Germany, France, Russia, and other European countries. For instance, in Germany approximately 1% of population are vegans in 2016 and is showing a positive growth rate from past few years. In addition, launch of newer products by the market players also boost the revenue of market over the forecast years

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • Global non-animal softgel capsules market expanding at significant CAGR over 2021 to 2027 due to growing demand from vegan population across the globe
  • Based on region, North America accounted for considerable market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

Key

Key Features of the Report

Non-Animal Softgel Capsules Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Yuwang Group
  • NBTY
  • Patheon (now Thermo Fisher Scientific)
  • Procaps
  • Lonza (Capsugel)
  • Aenova
  • Captek
  • EuroCaps
  • Sirio Pharma
  • Soft Gel Technologies
  • IVC
  • Strides Shasun
  • Baihe Biotech
  • Amway
  • Ziguang Group
  • Catalent
  • By-Health
  • Guangdong Yichao
  • Shineway
  • Donghai Pharm

Description

The global non-animal softgel capsules market size USD 360.2 million in 2020 and expected to reach USD 525.8 million by 2027, at a CAGR of 5.5% during forecast period 2021-2027. Gelatin is used as major raw material while making Softgel capsules. There is an increasing demand for natural and green products from health conscious customers hence driving the market growth and bringing more opportunities in for the players. Moreover, rise in awareness about the health among the population, increase in the demand for non-animal softgel capsules due to surge in vegan population and religious myths, wide range of advantages with softgel capsules such as compatibility with high temperature, and launch of newer products are anticipated to propel the non-animal softgel capsules market over the forecast years. However, Fluctuations in raw material prices, adoption of alternate nutritional products such as powders and injections, and complications in the manufacturing process are anticipated to restrain the growth of market in the near future. Adoption of nutritional supplements due to wide benefits with the products is a key factor surge the growth of global non-animal softgel capsules market over the forecast years. Softgel capsules are easily absorb and may enhance the bioavailability of the products. Rapid growth in global population demanding for vegan products may generate the revenue of market. Currently, approximately 45% capsules are made up of pork meat and bones and only 3% of the global softgel capsules production is from halal or permissible ingredients which is a major concern for the Muslim population may leads to surge in the adoption of vegan softgel capsules over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX